Nalu Medical, which works on the treatment of chronic pain, received an investment of $ 65 million. Novo Holdings led the $ 65 million investment round of US-based Nalu Medical. Other investors participating in the investment round; Aperture Venture Partners, Gilde Healthcare, Decheng Capital, MVM Partners, Longitude Capital, Pura Vida, Endeaver Vision and Advent Life Sciences.
Nalu Medical Focuses on Treating Chronic Pain
The US-based startup was founded in 2014 by Mike Partsch, Daniel Pivonka and Lee Hartley. The startup has developed a health technology that treats chronic pain. The startup is basically developing miniaturised neurostimulation implants. It also manages pain with the implants it has developed. The implants also use electrical signals to regulate neural activity in the body.
The implants are placed through a surgical procedure. In this way, chronic pain etc. treatment of ailments is also realised. The implants developed by Nalu Medical are connected to the spinal cord or peripheral nerves. This connection is provided by a thin electrical cable and pulse generators that do not require small batteries. Through the connections, the implants send electrical impulses to certain parts of the body. In this way, pain signals are blocked.
The startup first offers the technology it has developed on a temporary trial basis. In other words, how the person responds to the treatment is measured before switching to long-term treatment. As a result, users will be able to test whether the implants are suitable for them. As a result, personal experiences will be taken into account and an informed choice will be made about treatment options. Users will be able to observe the reaction of their own body during the test. They will also be able to easily understand which of the treatment options are suitable for them.